COSMIN guideline for systematic reviews of patient-reported outcome measures

CAC Prinsen, LB Mokkink, LM Bouter, J Alonso… - Quality of life …, 2018 - Springer
Purpose Systematic reviews of patient-reported outcome measures (PROMs) differ from
reviews of interventions and diagnostic test accuracy studies and are complex. In fact …

Fatigue as a symptom or comorbidity of neurological diseases

IK Penner, F Paul - Nature Reviews Neurology, 2017 - nature.com
Fatigue, best described as an overwhelming feeling of tiredness and exhaustion, occurs in
the context of various neurological diseases. The high prevalence of fatigue as either a …

Distinguishing between fatigue and fatigability in multiple sclerosis

RM Enoka, AM Almuklass, M Alenazy… - … and Neural Repair, 2021 - journals.sagepub.com
Fatigue is one of the most common debilitating symptoms reported by persons with multiple
sclerosis (MS). It reflects feelings of tiredness, lack of energy, low motivation, and difficulty in …

Exercise therapy for fatigue in multiple sclerosis

M Heine, I van de Port, MB Rietberg… - Cochrane database …, 2015 - cochranelibrary.com
Background Multiple sclerosis (MS) is an immune‐mediated disease of the central nervous
system affecting an estimated 1.3 million people worldwide. It is characterised by a variety of …

Psychometric properties of the fatigue severity scale and the modified fatigue impact scale

YC Learmonth, D Dlugonski, LA Pilutti… - Journal of the …, 2013 - Elsevier
OBJECTIVE: Fatigue is one of the most common, debilitating and life altering symptoms
experienced by those with multiple sclerosis (MS) and has become the focus of therapeutic …

[HTML][HTML] Disease-induced skeletal muscle atrophy and fatigue

SK Powers, GS Lynch, KT Murphy… - Medicine and science …, 2016 - ncbi.nlm.nih.gov
Numerous health problems including acute critical illness, cancer, diseases associated with
chronic inflammation, and neurological disorders often result in skeletal muscle weakness …

Role of inflammation in human fatigue: relevance of multidimensional assessments and potential neuronal mechanisms

B Karshikoff, T Sundelin, J Lasselin - Frontiers in immunology, 2017 - frontiersin.org
Fatigue is a highly disabling symptom in various medical conditions. While inflammation has
been suggested as a potential contributor to the development of fatigue, underlying …

Towards the implementation of 'no evidence of disease activity'in multiple sclerosis treatment: the multiple sclerosis decision model

M Stangel, IK Penner, BA Kallmann… - Therapeutic …, 2015 - journals.sagepub.com
Objective: The introduction of new and potent therapies for the treatment of relapsing
remitting multiple sclerosis (MS) has increased the desire for therapeutic success. There is …

[HTML][HTML] Fatigue in advanced kidney disease

M Artom, R Moss-Morris, F Caskey, J Chilcot - Kidney international, 2014 - Elsevier
Fatigue is commonly experienced in patients with advanced kidney disease and associated
with poor outcomes. The prevalence of fatigue ranges from 42% to as high as 89 …

Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: a systematic review

OL Aiyegbusi, D Kyte, P Cockwell, T Marshall… - PloS one, 2017 - journals.plos.org
Background Patient-reported outcome measures (PROMs) can provide valuable information
which may assist with the care of patients with chronic kidney disease (CKD). However …